Investigational Site Number :6430007

Moscow 117997

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis — Running, not enrolling
• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) — Completed